1Y Target$30.72Near-term target
5Y Target$43.02Compound horizon
10Y Target$63.23Long-dated conviction
FCF—TTM—FCF not applicable for this sector (bank / insurer / REIT) or data unavailable
Rev+88.7%TTM YoYARevenue +88.7% — hypergrowth, top decile
D/E1.08C+D/E 1.08 — moderately levered, watch interest coverage
P/E6.6xAP/E 6.6 — deep value; well below S&P median (~20x)
PEG0.07proxyAPEG 0.07 — exceptional; paying well under fair value for growth · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Construction · market cap $23.9b. Down 61% from 52-week high of $69.10 — deep drawdown territory. Revenue growing +89% — in hypergrowth territory. PEG 0.07 — paying under fair value for the growth rate.
Moat
Net margin 37% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 23% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Down 61% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
Horizon
1-3 yr $30.72 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $43.02 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $63.23 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.